ARTICLE | Clinical News
Connetics to seek Olux label expansion
November 5, 2001 8:00 AM UTC
CNCT said a 279-patient Phase IV study showed that patients with mild-to-moderate body psoriasis treated twice-daily for 14 days with Olux 0.05% clobetasol propionate foam for corticosteroid-responsiv...